This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Donaldson (DCI) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Donaldson's (DCI) Q3 revenues increase 6% year over year, driven by impressive performances of its Mobile Solutions and Industrial Solutions segments.
Donaldson (DCI) Rewards Shareholders With 8% Dividend Hike
by Zacks Equity Research
Donaldson's (DCI) measures to consistently reward shareholders through dividends and share buybacks hold promise.
Parker-Hannifin (PH) to Gain From Business Strength Amid Risks
by Zacks Equity Research
Parker-Hannifin (PH) is expected to benefit from business strength, acquired assets and shareholder-friendly policies. However, weakness in the Diversifies Industrial unit remains a concern.
Best Momentum Stocks to Buy for May 31st
by Zacks Equity Research
MNSO, LNTH and LXFR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 31, 2023.
Luxfer (LXFR) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
New Strong Buy Stocks for May 31st
by Zacks Equity Research
LXFR, FCBC, CMRE, MNSO and DLB have been added to the Zacks Rank #1 (Strong Buy) List on May 31, 2023.
Best Income Stocks to Buy for May 31st
by Zacks Equity Research
LXFR, FCBC and CMRE made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 31, 2023.
LXFR vs. CR: Which Stock Is the Better Value Option?
by Zacks Equity Research
LXFR vs. CR: Which Stock Is the Better Value Option?
Chart Industries (GTLS) Secures Compression Order in Portugal
by Zacks Equity Research
Chart Industries (GTLS) is set to supply two diaphragm compressors to Repsol for the Sines industrial complex in Portugal.
Nordson (NDSN) to Acquire Atrion & Boost Medical Offerings
by Zacks Equity Research
Nordson (NDSN) announces to acquire Atrion. This will enable it to strengthen its medical offerings and boost its position in the infusion and cardiovascular therapies market.
Best Momentum Stocks to Buy for May 29th
by Zacks Equity Research
DXPE, ENGIY and LXFR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 29, 2023.
New Strong Buy Stocks for May 29th
by Zacks Equity Research
DXPE, ENGIY, LXFR, YOU and CLS have been added to the Zacks Rank #1 (Strong Buy) List on May 29, 2023.
Best Income Stocks to Buy for May 29th
by Zacks Equity Research
LXFR, FFBC and FHN made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 29, 2023.
Are Industrial Products Stocks Lagging DXP Enterprises (DXPE) This Year?
by Zacks Equity Research
Here is how DXP Enterprises (DXPE) and Luxfer (LXFR) have performed compared to their sector so far this year.
Here's Why You Should Retain Cintas (CTAS) in Your Portfolio for Now
by Zacks Equity Research
Cintas (CTAS) benefits from strength in its businesses, focus on operational executions and shareholder-friendly policies. Escalating operating expenses remain a concern.
Zebra (ZBRA) Prices $500M Senior Notes in Private Offering
by Zacks Equity Research
Zebra (ZBRA) prices senior unsecured notes worth $500 million in aggregate principal amount. The net proceeds will be used to repay outstanding debt under the revolving credit facility.
Here's Why Flowserve (FLS) Stock Should Grace Your Portfolio
by Zacks Equity Research
Flowserve (FLS) gains from strength across its original equipment and aftermarket businesses, solid bookings and shareholder-friendly moves.
New Strong Buy Stocks for May 22nd
by Zacks Equity Research
LXFR, SGC, TRMK, MNSO and HHS have been added to the Zacks Rank #1 (Strong Buy) List on May 22, 2024.
Best Income Stocks to Buy for May 22nd
by Zacks Equity Research
LXFR, ASBFY and TRMK made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 22, 2024.
What Makes Luxfer (LXFR) a New Strong Buy Stock
by Zacks Equity Research
Luxfer (LXFR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RBC Bearings (RBC) Q4 Earnings Surpass Estimates, Up Y/Y
by Zacks Equity Research
RBC Bearings' (RBC) fourth-quarter fiscal 2024 adjusted earnings increase 16% year over year, driven by higher revenues.
Best Income Stocks to Buy for May 20th
by Zacks Equity Research
IVR, VLVLY and LXFR made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 20, 2024.
Kadant (KAI) Authorizes $50M Worth of Share Buyback Program
by Zacks Equity Research
Kadant (KAI) rewards shareholders with a share buyback program worth $50 million.
LXFR or NDSN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LXFR vs. NDSN: Which Stock Is the Better Value Option?
Here's Why Investors Should Retain Ingersoll Rand (IR) Now
by Zacks Equity Research
Ingersoll Rand (IR) gains from strength across its businesses, acquired assets and shareholder-friendly policies. However, softness in its life sciences business is concerning.